Table 3.
Distribution of samples according to methodology and positivity
| Microbiological study
|
Molecular study
|
|||||||
|---|---|---|---|---|---|---|---|---|
| Sample
|
Positives
|
Positives
|
||||||
| Tissue | n | Total | n | % (95% CI) | Total | n | % (95% CI) | P |
| Lung | 23 | 23 | 5 | 21.7 (3.9–63.0) | 23 | 6 | 26.1 (5.5–66.5) | 0.729 |
| Spleen | 19 | 19 | 3 | 15.8 (1.7–61.8) | 19 | 7 | 36.8 (8.8–77.0) | 0.140 |
| Liver | 23 | 23 | 5 | 21.7 (3.9–63.0) | 23 | 6 | 26.1 (5.5–66.5) | 0.729 |
| Intestine | 22 | 22 | 2 | 9.1 (0.6–25.8) | 22 | 4 | 18.2 (2.6–60.9) | 0.660 |
| Blood | 23 | 23 | 0 | 0 | 22 | 0 | 0 | |
| Muscle | 1 | 1 | 1 | 100 | 1 | 1 | 100 | |
| Bone | 1 | 1 | 1 | 100 | 1 | 1 | 100 | |
| Total | 112 | 112 | 17 | 15.2 (5.0–32.6) | 111 | 25 | 22.5 (10.4–41.0) | 0.161 |
95% CI — 95% confidence interval.